Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Immunogen
Immunogen
(IMGN)
ImmunoGen, Inc. (Nasdaq: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Elahere
Mirvetuximab soravtansine
2022-11-14
Fallopian tube neoplasms
,
Ovarian epithelial carcinoma
,
Peritoneal neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mirvetuximab soravtansine
recurrence
,
carcinoma
,
carcinosarcoma
,
hereditary breast and ovarian cancer syndrome
,
mullerian mixed tumor
,
neoplasms
,
endometrial neoplasms
,
serous cystadenocarcinoma
,
endometrioid carcinoma
,
adenocarcinoma
,
clear cell adenocarcinoma
,
acinar cell carcinoma
,
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
peritoneal neoplasms
Rucaparib
neoplasms
,
malignant mesothelioma
,
mesothelioma
,
adenocarcinoma
Rucaparib camsylate
neoplasms
,
malignant mesothelioma
,
mesothelioma
,
adenocarcinoma
Ado-trastuzumab emtansine
breast neoplasms
Lampalizumab
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
myeloid leukemia
Etrolizumab
healthy volunteers/patients
,
infections
,
leukemia
,
myeloid leukemia acute
,
neoplasms
,
myeloid leukemia
,
community-acquired infections
,
bacterial pneumonia
,
pneumonia
Lenograstim
pancreatic neoplasms
,
neoplasms
,
primary myelofibrosis
,
anemia
,
aplastic anemia
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
hematologic neoplasms
,
myeloproliferative disorders
,
lymphoma
,
graft vs host disease
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myelomonocytic leukemia chronic
,
prolymphocytic leukemia
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
lymphoid leukemia
Doconexent
healthy volunteers/patients
,
autoimmune diseases
,
psoriasis
Sodium chloride
skin aging
ANETUMAB RAVTANSINE
medical sociology
,
non-small-cell lung carcinoma
,
ovarian neoplasms
,
renal insufficiency
,
oncogenes
,
neoplasms
,
adenocarcinoma
,
mesothelioma
,
lung neoplasms
,
pancreatic neoplasms
,
malignant mesothelioma
,
carcinoma
,
endometrioid carcinoma
,
serous cystadenocarcinoma
,
adenocarcinoma of lung
Bevifimod
alzheimer disease
,
myelodysplastic syndromes
,
liver diseases
,
hepatic insufficiency
,
cognitive dysfunction
,
precursor cell lymphoblastic leukemia-lymphoma
,
maximum tolerated dose
,
antineoplastic protocols
,
pharmacokinetics
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
covid-19
,
aplastic anemia
,
paraproteinemias
,
monoclonal gammopathy of undetermined significance
,
lymphocytosis
,
laboratory infection
,
myeloid leukemia acute
,
castration-resistant prostatic neoplasms
,
myeloid leukemia
,
neoplasms
,
hiv infections
,
acquired immunodeficiency syndrome
,
hematologic neoplasms
,
hiv
,
immunologic deficiency syndromes
,
syndrome
,
hypergammaglobulinemia
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
prostatic neoplasms
,
neoplasm metastasis
,
multiple myeloma
,
plasma cell neoplasms
,
colorectal neoplasms
,
colonic neoplasms
,
colonic diseases
,
virus diseases
,
sexually transmitted diseases
,
retroviridae infections
,
viral sexually transmitted diseases
,
b-cell lymphoma marginal zone
,
burkitt lymphoma
,
tuberculosis
,
pulmonary tuberculosis
,
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
follicular lymphoma
,
lung neoplasms
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
renal insufficiency
,
respiratory syncytial viruses
,
psoriasis
,
ebola hemorrhagic fever
,
cerebrospinal fluid leak
,
hemorrhage
,
soft tissue injuries
,
respiratory tract diseases
,
kidney transplantation
,
prolymphocytic leukemia t-cell
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
leukemia
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
atrial fibrillation
,
glomerulonephritis
,
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
CANTUZUMAB RAVTANSINE
colorectal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
LORVOTUZUMAB MERTANSINE
multiple myeloma
,
plasma cell neoplasms
,
ovarian neoplasms
,
merkel cell carcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
recurrence
,
neoplasms
,
sarcoma
,
neuroblastoma
,
synovial sarcoma
,
rhabdomyosarcoma
,
neurofibrosarcoma
,
wilms tumor
,
nerve sheath neoplasms
,
pulmonary blastoma
,
leukemia
,
hematologic neoplasms
NARATUXIMAB EMTANSINE
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
Polyglycolic acid
alzheimer disease
,
psychomotor agitation
,
aggression
,
bipolar disorder
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use